Eating behavior in patients with metabolically associated fatty liver disease-Reference-Cited by-同舟云学术

Eating behavior in patients with metabolically associated fatty liver disease

Published:2024-05-18 Issue:5 Volume: Page:90-99
ISSN:1682-8658
Container-title:Experimental and Clinical Gastroenterology
language:
Short-container-title:ECG

Author:

Khalashte A. A.¹^ORCID,Lyalyukova E. A.²^ORCID,Zhachemuk S. K.¹,Beslangurova Z. A.¹,Zhernakova G. N.²^ORCID

Affiliation:

1. Maykop State Technological University

2. Omsk State Medical University

Abstract

The purpose of this study was to study the phenotypes of eating behavior in patients with NAFLD and their determining factors. Discussion: fatty liver disease has a high prevalence (24-26%) with an upward trend in both developed and developing countries, and in the coming years may become one of the main causes of liver transplantation. The clinical features of the disease are in most cases its asymptomatic course, which can progress to fibrosis/cirrhosis and is associated with the risk of a number of serious extrahepatic diseases (cardiovascular, oncological and others). The mechanisms underlying the formation of increased health risks and disease prognosis are multifactorial. Metabolic disorders, orthorexia nervosa, eating disorders and vegetative effects are considered as possible pathogenetic mechanisms for increasing the risk of NAFLD incidence. Conclusion: the study showed that complex behavioral psycho-social factors are involved in the pathogenesis of NAFLD, and changing eating behavior is an important component of therapy. Dysfunctional eating behavior can be a barrier to long-term success from therapy.

Publisher

LLC Global Media Technology

Reference21 articles.

1. Lazebnik L. B., Golovanova E. V., Turkina S. V. et al. Non-alcoholic fatty liver disease in adults: clinic, diagnosis, treatment. Recommendations for therapists, the third version. Experimental and clinical gastroenterology. 2021;185(1): 4-52. doi: 10.31146/1682-8658-ecg-185-1-4-52 (in Russ.)@@ Lazebnik L. B., Golovanova E. V., Turkina S. V. i soavt. Nealkogol'naya zhirovaya bolezn' pecheni u vzroslykh: klinika, diagnostika, lechenie. Rekomendatsii dlya terapevtov, tret'ya versiya. Eksperimental'naya i klinicheskaya gastroenterologiya. 2021;185(1): 4-52. doi: 10.31146/1682-8658-ecg-185-1-4-52

2. Ivashkin V. T., Mayevskaya M. V., Zharkova M. S. et al. Clinical recommendations of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the Russian Association of Endocrinologists, the Russian Association of Gerontologists and Geriatricians and the National Society of Preventive Cardiology for the diagnosis and treatment of non-alcoholic fatty liver disease.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022;32(4):104-140. doi: 10.22416/1382-4376-2022-32-4-104-140 (in Russ.)@@ Ivashkin V. T., Maevskaya M. V., Zharkova M. S. i soavt. Klinicheskie rekomendatsii Rossiiskogo obshchestva po izucheniyu pecheni, Rossiiskoi gastroenterologicheskoi assotsiatsii, Rossiiskoi assotsiatsii endokrinologov, Rossiiskoi assotsiatsii gerontologov i geriatrov i Natsional'nogo obshchestva profilakticheskoi kardiologii po diagnostike i lecheniyu nealkogol'noi zhirovoi bolezni pecheni. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2022;32(4):104-140. doi: 10.22416/1382-4376-2022-32-4-104-140.

3. Mayev I. V., Andreev D. N., Kucheryavy Yu. A. Metabolically associated fatty liver disease - a disease of the XXI century. Consilium Medicum. 2022;24(5):325-332. (in Russ.) doi: 10.26442/20751753.2022.5.201532.@@ Maev I. V., Andreev D. N., Kucheryavyi Yu. A. Metabolicheski assotsiirovannaya zhirovaya bolezn' pecheni - zabolevanie XXI veka. Consilium Medicum. 2022;24(5):325-332. (in Russ.) doi: 10.26442/20751753.2022.5.201532.

4. Kim G.A., Lee H. C., Choe J. et al. Association between non-alcoholic fatty liver disease and cancer incidence rate. J Hepatol. 2017 Nov 2: S0168-8278(17)32294-8. doi: 10.1016/j.jhep.2017.09.012.

5. Schwartz M.W., Seeley R. J., Zeltser L. M. et al. Obesity pathogenesis: an endocrine society scientific statement. Endocrine reviews. 2017;38: 267-296.